PAVmed’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

PAVmed develops, manufactures and supplies medical analytic devices for the treatment of esophageal diseases. Read more

Lishan Aklog's photo - Chairman & CEO of PAVmed

Chairman & CEO

Lishan Aklog

CEO Approval Rating

95/100

Founded:

2014

Status:

PublicNASDAQPAVM

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

NeoGenomics has been one of PAVmed's top competitors. NeoGenomics was founded in 2001, and is headquartered in Fort Myers, Florida. NeoGenomics competes in the Health Care Services industry. NeoGenomics generates $399.4M more revenue vs. PAVmed.

IDXG is a top competitor of PAVmed. IDXG is a Public company that was founded in Parsippany, New Jersey in 2014. Like PAVmed, IDXG also competes in the Biotechnology industry. IDXG has 167 more employees vs. PAVmed.

Cernostics is perceived as one of PAVmed's biggest rivals. Cernostics was founded in 2008, and its headquarters is in Pittsburgh, Pennsylvania. Cernostics competes in the Health Care Services field. Cernostics has 1 more employees than PAVmed.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is BioReference Laboratories a competitor of PAVmed?

Quarterly and Annual Revenue

Coming soon for PAVmed!

Annual Revenue

Acquisitions

No recent acquisitions found related to PAVmed

PAVmed Funding History

$845K$23.8M$31.3M$39.1M$53.1M$65.1M

Since PAVmed was founded in 2014, it has participated in 10 rounds of funding. In total PAVmed has raised $65.1M. PAVmed's last funding round was on Aug 2020 for a total of $7.8M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Aug 2020
$7.8M
Debt
Apr 2020
$4.1M
Debt - PPP (CARES Act)
Apr 2020
$150K - $350K

U.S. Small Business Administration.

Debt
Nov 2019
$14M
-
Debt
Dec 2018
$7.8M
-

Total Funding: $65.1M

Since PAVmed was founded in 2014, it has participated in 10 rounds of funding. In total PAVmed has raised $65.1M. PAVmed's last funding round was on Aug 2020 for a total of $7.8M

Investments

No recent investments found related to PAVmed

PAVmed News

August 16, 2020Zolmax News

PAVmed (PAVM) Scheduled to Post Earnings on Tuesday

PAVmed (NASDAQ:PAVM) is scheduled to post its quarterly earnings results after the market closes on T... See more »
August 12, 2020massdevice

Pavmed raises $7.8M

Pavmed (NSDQ:PAVM) filed an SEC Form D to confirm the sale of $7.75 million in an offering of debt an... See more »
August 6, 2020MarketScreener

PAVmed Secures $7 Million Convertible Note Financing

(marketscreener.com) NEW YORK, Aug. 06, 2020 -- PAVmed Inc. , a highly differentiated, multi-product,... See more »
July 13, 2020MarketScreener

PAVmed to Present at Maxim Group's COVID-19 Webinar on July 16, 2020

(marketscreener.com) NEW YORK, July 13, 2020 -- PAVmed Inc. , a highly differentiated, multi-product,... See more »
June 22, 2020Zolmax News

PAVmed (NASDAQ:PAVM) & Interpace Diagnostics Group (NASDAQ:IDXG) Head-To-Head Survey

Interpace Diagnostics Group (NASDAQ:IDXG) and PAVmed (NASDAQ:PAVM) are both small-cap medical compani... See more »

PAVmed Press Releases

April 9, 2020StreetInsider

PAVmed Reports Preliminary Fourth Quarter 2019 Financial Results and Provides Business Update

Conference call to be held today at 4:30 p.m. Eastern time NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) ... See more »
March 9, 2020StreetInsider

PAVmed Announces FDA 510(k) Re-submission for its CarpX Minimally Invasive Carpal Tunnel Device

Incorporates data from successful clinical safety study in which all patients met pre-specified safet... See more »
November 6, 2019GlobalNewswire

PAVmed to Hold Business Update Conference Call on November 21, 2019

NEW YORK, Nov. 06, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVm... See more »
November 5, 2019GlobalNewswire

PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization

Extends cash runway to support multiple milestones including commercialization of two lead products... See more »

PAVmed Videos

June 4, 2019PAVmed Youtube Channel

"DDW 2019 Timelapse" on YOUTUBE

March 26, 2019PAVmed Youtube Channel

"NextFlo Infusion System Demo" on YOUTUBE

November 9, 2018PAVmed Youtube Channel

"EsoCheck Presentation at ACG" on YOUTUBE

August 21, 2018PAVmed Youtube Channel

"PAVmed Corporate Video" on YOUTUBE

August 20, 2018PAVmed Youtube Channel

"DisappEAR by PAVmed" on YOUTUBE

Headquarters

One Grand Central Place Suite 4600

New York, New York10165

212-949-4319

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

PAVmed develops, manufactures and supplies medical analytic devices for the treatment of esophageal diseases. PAVmed was founded in 2014. PAVmed's headquarters is located in New York, New York, USA 10165. It has raised 65.1M in 10 rounds. The latest r...

CEO

PAVmed's Chairman & CEO, Lishan Aklog, currently has an approval rating of 95%. PAVmed's primary competitors are NeoGenomics, IDXG & Cernostics.

Website

pavmed.com

Frequently Asked Questions about PAVmed

  1. When was PAVmed founded?

    PAVmed was founded in 2014
  2. Who is PAVmed's CEO?

    PAVmed's CEO is Lishan Aklog
  3. How much revenue does PAVmed generate?

    PAVmed generates $ < 1M in revenue
  4. How much funding does PAVmed have?

    PAVmed has historically raised $65.1M in funding
  1. Where is PAVmed's headquarters?

    PAVmed's headquarters is in New York New York, USA
  2. How many employees does PAVmed have?

    PAVmed has 9 employees
  3. What sector does PAVmed operate in?

    PAVmed is in Biotechnology
  4. Who are PAVmed's competitors?

    PAVmed's top competitors are NeoGenomics, IDXG, Cernostics